IL16 and colitis: In a mouse model of colitis-associated colon cancer, a macrophage-specific knockout (KO) of gp96 contributes to colitis and tumorigenesis by enhancing the production of inflammatory cytokines, such as IL-17, IL-23, IL-12, IL-16, and IFN-γ.